Home > Insider Trading > Filing (0000899243-20-000700)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492674	T2 Biosystems Inc.	TTOO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292650	B David Elsbree	101 Hartwell Avenue Lexington MA 02421		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-01-03	5,316	$1.16	91,081	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,000	Indirect	By spouse

Footnotes

The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2019, to cover payment of tax liability incident to the vesting of restricted stock units.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.14 to $1.17. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.